UPDATE : Friday, August 23, 2019
상단여백
SK Biopharmaceuticals, Arvelle to develop, commercialize cenobamate in Europe
SK Biopharmaceuticals said Thursday that it has signed an exclusive licensi...
by Lee Han-soo  |  2019-02-15 15:36
라인
Acute myeloid leukemia treatment Rydapt approved as orphan drug
The regulatory agency approved Rydapt 25mg (ingredient: midostaurin), a tre...
by Lee Hye-seon  |  2019-02-15 15:36
라인
Sanofi Genzyme Korea launches rare blood disorder franchise
Sanofi Genzyme Korea, a subsidiary of Sanofi, said Thursday that it has lau...
by Lee Han-soo  |  2019-02-15 14:37
라인
GC starts P2 trials of hepatitis B treatment
GC said Thursday that it has administered the first dose of GC1102, a new r...
by Lee Han-soo  |  2019-02-15 14:36
라인
MSD leads rapidly growing antidiabetic DPP-4 inhibitors market
MSD took the No. 1 position in sales of antidiabetic dipeptidyl peptidase-4...
by Kim Yun-mi  |  2019-02-15 14:31
라인
Dong-A ST posts ₩567.2 billion in 2018 sales
Dong-A ST said Wednesday that it recorded the sales of 567.2 billion ($504....
by Lee Han-soo  |  2019-02-14 16:13
라인
Blood-thinning NOAC market expands 30% in 2018
The domestic market of non-vitamin K antagonist oral anticoagulants (NOAC) ...
by Kim Yun-mi  |  2019-02-14 12:12
라인
Yuhan’s subsidiary wins ₩43.5 billion funding
ImmuneOncia Therapeutics said Wednesday that it has completed a private equ...
by Lee Han-soo  |  2019-02-13 17:04
라인
Price cut, expanded indication to prop up cholesterol-reducing PCSK9 inhibitors
Physicians are likely to use cholesterol-lowering proprotein convertase sub...
by Kim Yun-mi  |  2019-02-13 16:11
라인
Mediforum gets ₩19 billion investment
Mediforum said Wednesday that it has received investment worth 19 billion w...
by Lee Han-soo  |  2019-02-13 15:19
라인
Genexine, SCM Life Science acquire Argos Therapeutics
Genexine and SCM Life Science said Wednesday that they took over Argos Ther...
by Lee Han-soo  |  2019-02-13 15:17
라인
CJ Healthcare to export gastroesophageal reflux treatment to Latin America
CJ Healthcare said Wednesday that it has signed a licensing agreement for K...
by Lee Han-soo  |  2019-02-13 10:50
라인
GC posts ₩1.3 trillion in 2018 sales
GC said Wednesday that it has recorded 1.3 trillion won ($1.1 billion) in s...
by Lee Han-soo  |  2019-02-13 10:50
라인
Bridge Biotherapeutics unveils clinical trials results for ulcerative colitis treatment
Bridge Biotherapeutics said it presented the preclinical and phase 1 study ...
by Lee Han-soo  |  2019-02-12 17:38
라인
AbbVie’s new hepatitis C treatment outpaces Gilead’s rival drugs
AbbVies’s new hepatitis C therapy Mavyret (glecaprevir/pibrentasvir), a fol...
by Kim Yun-mi  |  2019-02-12 15:56
라인
Pfizer Korea voluntarily recalls antibiotic Zyvox
Pfizer Korea said it voluntarily recalled some of Zyvox 600mg (ingredient: ...
by Lee Hye-seon  |  2019-02-12 15:56
라인
SK Chemical to co-promote Janssen’s dementia treatment
SK Chemical said Tuesday that it has signed an agreement with Janssen Korea...
by Lee Han-soo  |  2019-02-12 15:55
라인
Demands for MMR vaccines spike amid resurgence of measles
Amid a rise of measles patients, clinics are suffering a shortage of MMR (m...
by Park Gi-taek  |  2019-02-12 11:19
라인
IVI to cooperate with CEPI to develop vaccines
International Vaccine Institute (IVI) said it has signed a partner service ...
by Lee Han-soo  |  2019-02-11 16:41
라인
Gilead’s hepatitis B drug posts disappointing sales in 2018
Gilead Sciences Korea’s hepatitis B treatment Vemlidy (ingredient: tenofovi...
by Kim Yun-mi  |  2019-02-11 15:29
여백
여백
여백
Back to Top